IL6 and COVID-19: High levels of proinflammatory cytokines, such as IL-1, IL-6, IL-7, IL-12, IFN-γ, TNF-α, IP-10, MIP-1A, MCP-1, GCSF, and IP-10, have been observed in COVID-19 patients and are generally associated with severe lung damage [83–85].